|
Weekly Top Stories |
Mon, 18 May 2020 |
We have 24 articles this week. The week’s biggest highlights are : #TheDNACompany Acquires #AIDigitalTherapeutics App for $30M to Form My Next Health. #AbbVie Completes Transformative Acquisition of #Allergan. #NetHealth Acquires #TissueAnalytics. With $20 Million, #Immunai Emerges from Stealth Mode to Map Entire Immune System. Digital mental health company #Meru snags $8.1M in Series A funds. #UnitedHealthGroup, #Microsoft Launches Free App that Screens Employees for COVID-19 Symptoms. #IsraelInnovationAuthority Launches Pilot with #MayoClinic, #HartfordHealth, Others. |
Editor's Choice |
1.
|
Global Metabolic Disorders Drugs Market 2020-2026 | COVID19 Impact Analysis -zealand Pharma, Rhythm, Oxthera, Biophytis, Biophytis, Zafgen, Perkinelmer |
2.
|
After Covid-19, Where Does the US Pharma and Biotech Industry Stand? |
3.
|
Pharmaceutical Asset Managements Market Overview with Detailed Analysis, Competitive Landscape, Forecast to 2026| |
4.
|
Exclusive Demand for Diabetic Neuropathic Pain Drug Market Projected to Witness Vigorous Expansion by 2020-2027 by Major innovators like Astellas Pharma, AstraZeneca Plc |
5.
|
Impact of COVID-19 Outbreak on Specialty Pharmaceutical Market 2020 |
Top 10 M&A Transactions |
6.
|
The DNA Company Acquires AI Digital Therapeutics App for $30M to Form My Next Health |
7.
|
Net Health Acquires Tissue Analytics |
8.
|
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-Oncology Portfolio |
9.
|
Biopharmx Corporation Announces Approval of Merger By Stockholders at Special Meeting |
10.
|
Smiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access Offering |
11.
|
Minerva Surgical® Announces Acquisition Closing of Boston Scientific Intrauterine Health Products |
12.
|
TearLab Announces Acquisition By Accelmed Partners And Related $25 Million Investment |
13.
|
AbbVie Completes Transformative Acquisition of Allergan |
14.
|
Primary Healthcare Aggregator HealthAssure Acquires Digital Wellness Platform FitMeIn |
15.
|
BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals |
Top 3 Venture Funding |
16.
|
With $20 Million, Immunai Emerges from Stealth Mode to Map Entire Immune System |
17.
|
Digital Mental Health Company Meru Snags $8.1M in Series A Funds |
18.
|
Helium Health Closes $10M Series A, Led By Dubai Venture Capital Fund |
Top 4 Partnerships Announcements |
19.
|
UnitedHealth Group, Microsoft Launches Free App That Screens Employees for COVID-19 Symptoms |
20.
|
Bayer and ArcherDX Announce Global Collaboration to Develop Next-Generation Sequencing (NGS)-based Companion Diagnostic (CDx) for VITRAKVI® (larotrectinib) |
21.
|
Israel Innovation Authority Launches Pilot with Mayo Clinic, Hartford Health, Others |
22.
|
Cue Biopharma Announces Strategic Research Collaboration with Dr. Michael Dustin and Oxford University |
|
Read More Corporate Development and M&A Activity |
|
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
|
|
|
Editor: Ed Francis
Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.
If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073
Or connect with him at
|
|
OTHER ADVISORIES
|
Advertise with us
We Reach Half Million Decision Makers in: Healthcare · IT · Retail · IndustrialAdvertise with us and reach the right audience. advertise@distilnfo.com
|
Contact Us
5760 Legacy Dr, B3-405, Plano TX 75024
|
+1 469-270-3311
|
|
DistilINFO Publications
DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.
You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.
View in browser | Advertise | Contact Us
|
|
|